HemoGenix, Inc

is a contract research service laboratory specializing in in vitro toxicity testing that even large CROs cannot provide. The company, founded in 2000, has developed proprietary in vitro testing platforms, utilized by small, medium, and half of the top 50 biopharmaceutical companies. HemoGenix® prides itself on attention to detail, high-quality service, and personal consultation, providing expertise to help predict drug or agent toxicity, risk, and safety. Their expanding portfolio of contract research services includes in vitro testing of cells and tissues from GLP or non-GLP pre-clinical animal studies. The company's services are also available through Science Exchange. The company's slogan, "Advancing the Biopharmaceutical Community by Providing Advanced In Vitro Toxicity Testing and Research Services," reflects its commitment to the biopharma and biotechnology industries. HemoGenix®'s dedication to providing advanced in vitro toxicity testing sets it apart from other players in the industry. For individuals interested in assay kits, cell expansion reagents, and cell culture media, www.preferred-cell-systems.com or (719) 264-6251 offers these products. HemoGenix® looks forward to working with companies in the biopharmaceutical community, offering advanced in vitro toxicity testing and research services.